Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ADME pharmacogenetics: current practices and future outlook.

Expert opinion on drug metabolism & toxicology - 1 May 2009

Grossman Iris

Abstract excerpt

BACKGROUND: Genetic variants of ADME (absorption, distribution, metabolism and elimination) related genes have been consistently associated with pharmacokinetic properties of numerous drugs. However, the association between these genetic markers and clinical outcomes remains controversial. OBJECTIVE: Inform future pharmacogenetic ADME research and define the terms and practices for the utility of this approach....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholinesterase and Neurodegenerative Diseases
Share to Cost-Benefit Analysis
Share to Drug Design

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Pharmacogenetics

Share to Pharmacogenetics and Drug Metabolism

Share to Pharmacokinetics

Share to Phenotype

Source

Identifiers

PMID: 19416082
DOI: 10.1517/17425250902902322

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ADME pharmacogenetics: current practices and future outlook.PMID 19416082Read ↗

Development of a broad-based ADME panel for use in pharmacogenomic studies.Semantic proximity Read ↗

PhRMA white paper on ADME pharmacogenomics.Semantic proximity Read ↗

The Role of ADME Pharmacogenomics in Early Clinical Trials: Perspective of the Industry Pharmacogenomics Working Group (I-PWG)Semantic proximity Read ↗

Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation PerspectivesSemantic proximity Read ↗

Characterization of ADME gene variation in 21 populations by exome sequencing.Semantic proximity Read ↗

Current progress in pharmacogenetics.Semantic proximity Read ↗

Pharmacogenomic approaches in clinical studies to identify biomarkers of safety and efficacy.Semantic proximity Read ↗

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?Semantic proximity Read ↗

Clinically relevant genetic variations in drug metabolizing enzymes.Semantic proximity Read ↗

Brazilian cohort and genes encoding for drug-metabolizing enzymes and drug transporters.Semantic proximity Read ↗

Impact of drug transporter pharmacogenomics on pharmacokinetic and pharmacodynamic variability - considerations for drug development.Semantic proximity Read ↗

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.